Literature DB >> 25882307

Safety and compliance of a complex homeopathic drug (Contramutan N Saft) in the treatment of acute respiratory tract infections: A large observational (non-interventional) study in children and adults focussing on homeopathy specific adverse reactions versus adverse drug reactions.

Andreas Michalsen1, Bernhard Uehleke2, Rainer Stange2.   

Abstract

BACKGROUND: This non-interventional study was performed to generate data on safety and treatment effects of a complex homeopathic drug (Contramutan N Saft). PATIENTS AND METHODS: 1050 outpatients suffering from common cold were treated with the medication for 8days. The study was conducted in 64 outpatient practices of medical doctors trained in CAM. Tolerability, compliance and the treatment effects were assessed by the physicians and by patient diaries. Adverse events were collected and assessed with specific attention to homeopathic aggravation and proving symptoms. Each adverse effect was additionally evaluated by an advisory board of experts.
RESULTS: The physicians detected 60 adverse events from 46 patients (4.4%). Adverse drug reactions occurred in 14 patients (1.3%). Six patients showed proving symptoms (0.57%) and only one homeopathic aggravation (0.1%) appeared. The rate of compliance was 84% in average for all groups and the global assessment of the treatment effects attributed to "good" and "very good" in 84.9% of all patients.
CONCLUSIONS: The homeopathic complex drug was shown to be safe and effective for children and adults likewise. Adverse reactions specifically related to homeopathic principles are very rare. All observed events recovered quickly and were of mild to moderate intensity.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Acute respiratory tract infection; Adverse events; Dosage; Echinacea angustifolia; Eupatorium perfoliatum; Homeopathic aggravation; Mother tincture; Non-interventional study; Proving symptoms; Safety

Mesh:

Substances:

Year:  2015        PMID: 25882307     DOI: 10.1016/j.yrtph.2015.04.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  5 in total

1.  A Comparative Randomized Controlled Clinical Trial on the Effectiveness, Safety, and Tolerability of a Homeopathic Medicinal Product in Children with Sleep Disorders and Restlessness.

Authors:  Miek C Jong; Lydia Ilyenko; Irina Kholodova; Cynthia Verwer; Julia Burkart; Stephan Weber; Thomas Keller; Petra Klement
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-08       Impact factor: 2.629

2.  The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial.

Authors:  Robert van Haselen; Manuela Thinesse-Mallwitz; Vitaliy Maidannyk; Stephen L Buskin; Stephan Weber; Thomas Keller; Julia Burkart; Petra Klement
Journal:  Glob Pediatr Health       Date:  2016-07-04

3.  Paradigm-Specific Risk Conceptions, Patient Safety, and the Regulation of Traditional and Complementary Medicine Practitioners: The Case of Homeopathy in Ontario, Canada.

Authors:  Nadine Ijaz
Journal:  Front Sociol       Date:  2020-01-21

4.  Qinbaohong Zhike Oral Liquid Attenuates LPS-Induced Acute Lung Injury in Immature Rats by Inhibiting OLFM4.

Authors:  Fangbo Zhang; Yu Li; Yujie Xi; Yi Zhang; Lifang Wang; He Xu; Jixiang Tian; FeiFei Guo; Hongjun Yang
Journal:  Oxid Med Cell Longev       Date:  2022-08-16       Impact factor: 7.310

5.  Effectiveness, safety and tolerability of a complex homeopathic medicinal product in the prevention of recurrent acute upper respiratory tract infections in children: a multicenter, open, comparative, randomized, controlled clinical trial.

Authors:  Miek C Jong; Stephen L Buskin; Lydia Ilyenko; Irina Kholodova; Julia Burkart; Stephan Weber; Thomas Keller; Petra Klement
Journal:  Multidiscip Respir Med       Date:  2016-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.